Market by Product, Application, End-user, and Country | Forecast 2021-2028
The finding of an in-depth study conducted by Triton Market Research shows that the North America digital genome market will progress at a CAGR of 9.75% in terms of revenue for the forecast period between 2021 and 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries studied in this market are:
• The United States
• Canada
One
of the prime reasons contributing to the digital revolution in the field of
biology DNA sequencing that enables reading the genomes of a plethora of
microbes and multi-cellular organisms populating the world. Also, the microbial
genomes’ DNA sequences are deposited in databases of digital genomes, which
have exponentially increased the understanding of the functioning of DNA
program living systems. In Canada, the growing application area of personalized
medicine is predicted to direct its digital genome market on a growth path. The
future of medicine has been estimated to be data-driven, and focused on
developing personalized medicines for every patient on the basis of their
molecular profile.
Personalized
medicine (also called molecular medicine or precision medicine) would enable a
more precise disease diagnosis and also guide therapeutic interventions,
especially for treating infectious disease, cancer, lung disease, heart
disease, and neurological disorders. Personalized medicine is one of the
potential ways to provide more effective treatment, while also improving
patient care, which will help control costs. This is expected to become
increasingly important, as the patient volume continues to grow, and, in turn,
aid the adoption of digital genomes in Canada and boost the growth of the
studied market.
Pacific
Biosciences of California Inc is a US-based biotech firm established in 2004.
It is engaged in developing and manufacturing systems for gene sequencing and
some novel real-time biological observation. Pacbio Sequel Systems and SMRT
Analysis Software ae some of the company’s offerings. Pacific Biosciences is
headquartered in Menlo Park, California. The company has a strong base of reliable
raw material suppliers, which enables it to overcome any supply chain
bottlenecks.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
NORTH AMERICA DIGITAL GENOME
MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON DIGITAL GENOME MARKET
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. VENDOR
LANDSCAPE
2.5. KEY
INSIGHTS
2.6. KEY
DRIVERS
2.6.1. PROLIFERATING
BURDEN OF CHRONIC DISEASES
2.6.2. CONTINUOUS
FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS
2.7. KEY
RESTRAINTS
2.7.1. SECURITY
RISKS ASSOCIATED WITH DIGITAL GENOME
2.7.2. LACK
OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY
2.8. KEY
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS
2.8.2. PREVAILING
AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES
3.
DIGITAL GENOME MARKET OUTLOOK
- BY PRODUCT
3.1. SEQUENCING
AND ANALYZER INSTRUMENTS
3.2. DNA/RNA
ANALYSIS
3.3. SEQUENCING
AND ANALYSIS SOFTWARE
3.4. SEQUENCING
CHIPS
3.5. SAMPLE
PREP INSTRUMENTS
4.
DIGITAL GENOME MARKET OUTLOOK
- BY APPLICATION
4.1. DIAGNOSTICS
4.2. DRUG
DISCOVERY
4.3. ACADEMIC
RESEARCH
4.4. PERSONALIZED
MEDICINE
4.5. AGRICULTURAL
4.6. OTHER
APPLICATIONS
5.
DIGITAL GENOME MARKET OUTLOOK
- BY END-USER
5.1. DIAGNOSTICS
AND FORENSIC LABS
5.2. ACADEMIC
RESEARCH INSTITUTES
5.3. HOSPITALS
5.4. OTHER
END-USERS
6.
DIGITAL GENOME MARKET - NORTH
AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. THE
UNITED STATES
6.1.2. CANADA
7.
COMPANY PROFILE
7.1. QIAGEN
NV
7.2. OXFORD
NANOPORE TECHNOLOGIES LTD
7.3. BECTON,
DICKINSON, AND COMPANY (BD)
7.4. ILLUMINA
INC
7.5. THERMO
FISHER SCIENTIFIC INC
7.6. PACIFIC
BIOSCIENCE
7.7. BIO-RAD
LABORATORIES INC
7.8. F.
HOFFMANN-LA ROCHE
7.9. PERKINELMER
INC
7.10. REGENERON
PHARMACEUTICALS
7.11. BIOMERIEUX
SA
7.12. ABBOTT
LABORATORIES
7.13. AGILENT
TECHNOLOGIES INC.
7.14. INSCRIPTA
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1: NORTH AMERICA DIGITAL GENOME
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
2: VENDOR LANDSCAPE
TABLE
3: NORTH AMERICA DIGITAL GENOME
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
4: NORTH AMERICA DIGITAL GENOME
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE
5: NORTH AMERICA DIGITAL GENOME
MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE
6: NORTH AMERICA DIGITAL GENOME
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: NORTH AMERICA DIGITAL GENOME
MARKET, 2021-2028 (IN $ MILLION)
FIGURE
2: NORTH AMERICA DIGITAL GENOME
MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE
3: NORTH AMERICA DIGITAL GENOME
MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE
4: NORTH AMERICA DIGITAL GENOME
MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE
5: NORTH AMERICA DIGITAL GENOME
MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
FIGURE
6: NORTH AMERICA DIGITAL GENOME
MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE
7: NORTH AMERICA DIGITAL GENOME
MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE
8: NORTH AMERICA DIGITAL GENOME
MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE
9: NORTH AMERICA DIGITAL GENOME
MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE
10: NORTH AMERICA DIGITAL GENOME MARKET,
BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE
11: NORTH AMERICA DIGITAL GENOME MARKET,
BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
FIGURE
12: NORTH AMERICA DIGITAL GENOME MARKET,
BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
13: NORTH AMERICA DIGITAL GENOME MARKET,
BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
FIGURE
14: NORTH AMERICA DIGITAL GENOME MARKET,
BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE
15: NORTH AMERICA DIGITAL GENOME MARKET,
BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
16: NORTH AMERICA DIGITAL GENOME MARKET,
BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE
17: NORTH AMERICA DIGITAL GENOME MARKET,
2021-2028 (IN $ MILLION)
FIGURE
18: THE UNITED STATES DIGITAL GENOME
MARKET, 2021-2028 (IN $ MILLION)
FIGURE
19: CANADA DIGITAL GENOME MARKET,
2021-2028 (IN $ MILLION)